Robert Heft, Ph.D., President & Chief Executive Officer
Upon completion of his doctorate at the Massachusetts Institute of Technology in 1986, Dr. Heft joined Continental Pharma Cryosan as its Research Director. Shortly thereafter, he founded IBEX Technologies (Montreal, Quebec) and served as its President until 2001. In 2001, Dr. Heft joined BioMarin Pharmaceutical Inc. (Novato, California) as Vice-President Product Development, after BioMarin acquired the pharmaceutical assets of IBEX. Dr. Heft joined Enobia as President and CEO in 2005. Dr. Heft has served as a Director of the Industrial Biotechnology Association of Canada, the Canadian Genetic Disease Network and of BioCapital a life-sciences venture fund.
Back